Annovis Bio Develops
Transformative Therapies that Treat 

NEURODEGENERATIVE DISORDERS

 

We attack neurodegeneration by reducing neurotoxic proteins and therefore improving AXONAL TRANSPORT.

We enhance the FLOW of information along the Information highway of nerve cell.

WE ARE DEVELOPING DRUGS FOR ALZHEIMER’S DISEASE, PARKINSON’S DISEASE, AND OTHER NEURODEGENERATIVE DISORDERS

Our novel approach to addressing chronic and acute neurodegeneration offers new hope in the fight against the largest unmet need of an aging population

old young crop.jpg
people graphic.png

5.8M

Americans with Alzheimer's Disease

increase white.png

Increase in Alzheimer diagnoses by 2060

3x

failure icon.png

Failed drug development attempts since 1998

130

Neurotoxic proteins reduce axonal transport and cause a 
TOXIC CASCADE 

Impaired axonal transport lowers levels of neurotransmitters and neurotrophic proteins leading to nerve cell death.

We Are Working to
REVERSE

the Toxic Cascade

Plaques, tangles, and Lewy bodies represent the end stage of neurodegeneration. The disease STARTS with impaired axonal transport caused by high levels of neurotoxic proteins.